Interleukin-15: A Novel Cytokine with Regulatory Properties on Normal and Neoplastic B Lymphocytes

References

• O'Brien S., Del Giglio A., Keating M. Advances, in the biology and treatment of B-cell chronic lymphocytic leukemia. Blood 1995; 85: 307–318
   PubMed Web of Science ®Google Scholar
• Harris N. L., Jaffe E. S., Stein H., Banks P. M., Chan J. K. C., Cleary M. L., Delsol G., De Wolf-Peeters C., Falini B., Gatter K. C., Grogan T. M., Isaacson P. G., Knowles D. M., Mason D. Y., Mueller-Hermeling H. K., Pileri S. A., Piris M. A., Ralfkiaer E., Warnke R. A. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361–1392
   PubMed Web of Science ®Google Scholar
• Foon K. A., Rai K. R., Gale R. P. Chronic lymphocytic leukemia: new insights into biology and therapy. Ann Inter Med 1990; 113: 525–539
   PubMed Web of Science ®Google Scholar
• Cheson B. D., Bennet J. M., Grever M., Kay N., Keating M. J., O'Brien S., Rai K. R. National Cancer Institute-sponsored working group for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 1996; 87: 4990–4997
   PubMed Web of Science ®Google Scholar
• Bouroncle B. A., Wiseman B. K., Doan C. A. A. Leukemic reticuloendotlieliosis. Blood 1958; 13: 609–630
   PubMed Web of Science ®Google Scholar
• Cawley J. C., Worman C. P. Hairy cell leukaemia. Br J Haematol 1985; 60: 213–221
   PubMed Web of Science ®Google Scholar
• Caligaris-Cappio F. B-chronic lymphocytic leukemia: a malignancy of anti-self B-cells. Blood 1996; 87: 2615–2620
   PubMed Web of Science ®Google Scholar
• Cerutti A., Trentin L., Zamhello R., Sancetta R., Milani A., Tassinari C., Adami F., Agostini C., Semenzato G. The CD5/CD72 receptor system is coexpressed with several functionally relevant counterstructures on human B cells and delivers a critical signaling activity. J Immunol 1996; 157: 1854–1862
   PubMed Web of Science ®Google Scholar
• Foon K., Todd R. F. I. Immunologic classification of leukemia and lymphoma. Blood 1986; 68: 1–31
   PubMed Web of Science ®Google Scholar
• Posnett D. N., Wang C.-Y., Chiorazzi N., Crow M. K., Kunkel H. G. An antigen characteristic of hairy cell leukemia cells is expressed on certain activated B-cells. J Immunol 1984; 133: 1653–1659
   Google Scholar
• Ford R. J., Yoshimura L., Morgan J., Quesada J., Montagna R., Maizel A. Growth factor-mediated tumor cell proliferation in hairy cell leukemia. J Exp Med 1985; 162: 1093–2002
   PubMed Web of Science ®Google Scholar
• Cordingley F. T., Bianchi A., Hoffbrand A. V., Reittic J. E., Heslop H. E., Vyakarnam A., Turner M., Meager A., Brenner M. K. Tumour necrosis factor as an autocrine tumour growth factor for chronic B-cell malignancies. Lancet 1988; i: 969–971
   Google Scholar
• Digel W., Stcfanic M., Schoniger W., Buck C., Raghavachar A., Frickhofen N., Heimpel H., Porzsolt F. Tumor-necrosis factor induces proliferation of neoplastic B cells from chronic lymphocytic leukemia. Blood 1989; 73: 1242–1246
   PubMed Web of Science ®Google Scholar
• Trentin L., Zambello R., Agostini C., Enthammer C., Cerutti A., Adami F., Zamboni S., Semenzato G. Expression and regulation of tumor necrosis factor. inter-leukin-2, and hematopoietic growth factor receptors in B-cell chronic lymphocytic leukemia. Blood 1994; 84: 4249–4256
   PubMed Web of Science ®Google Scholar
• Trentin L., Zambello R., Pizzolo G., Vinantc F., Ambrosetti A., Chisesi T., Vespignani M., Feruglio C., Agostini C., Semenzato G. Tumor necrosis factor-alpha and B cell growth factor induce lcukemic hairy cells to proliferate in vitro. Cancer Det Prev. 1981; 15: 385–390
   Google Scholar
• Foa R., Guarini A., Francia di Celle P., Trentin L., Gillio Tos A., Bellone G., Carbone A., Attisano C., Massaia M., Raspadori D., Pizzolo G., Chisesi T., Lauria F., Semenzato G. Constitutive production of tumor necrosis factor-alpha in hairy ccll leukemia: possible role in the pathogenesis of the cytopenia(s) and effecta of treatment with interferon-alpha. J Clin Oncol 1992; 10: 954–959
   PubMed Web of Science ®Google Scholar
• Digel W., Schoniger W., Stefanic M., Janssen H., Buck C., Schmid M., Raghavachar A., Porzsolt F. Receptors for tumor necrosis factor on neoplastic B-cells from chronic lymphocytic leukemia are expressed in vitro but not in vivo. Blood 1990; 76: 1607–13
   PubMed Web of Science ®Google Scholar
• Trentin L., Zambello R., Agostini C., Siviero F., Adami F., Marcolongo R., Raimondi R., Chisesi T., Pizzolo C., Semenzato G. Expression and functional role of tumor necrosis factor receptors on leukemic cells from patients with type B chronic lymphoproliferative disorders. Blood 1993; 81: 752–758
   PubMed Web of Science ®Google Scholar
• Touw I., Dorssers L., Lowenberg B. The proli-ferative response of B cell chronic lymphocytic leukemia to interleukin 2: functional characterization of the interleukin 2 membrane receptors. Blood 1987; 69: 1667–1673
   PubMed Web of Science ®Google Scholar
• Trentin L., Zambello R., Benati C., Cassatella M., Agostini C., Bulian P., Adami F., Carra G., Pizzolo G., Semenzato G. Expression and functional role of the p75 interleukin 2 receptor chain on leukemic hairy cells. Cancer Res 1990; 52: 5223–5228
   Web of Science ®Google Scholar
• Trentin L., Cerutti A., Zambello R., Sancetta R., Tassinari C., Facco M., Adami F., Rodeghiero F., Agostini C., Semenzato G. Interleukin-15 promotes the growth of leukemic cells of patients with B-cell chronic lymphoproliferalive disorders. Blood 1996; 87: 3327–3335
   PubMed Web of Science ®Google Scholar
• Grabstein K. H., Eisenman J., Shanebeck K., Rauch C., Srinivasan S., Fung V., Beers C., Richardson J., Schoenborn M. A., Ahdieh M., Johnson L., Alderson M. R., Watson J. D., Anderson D. M., Giri J. G. Cloning of a T-cell growth factor that interacts with the β chain of the interleukin-2 receptor. Science 1994; 264: 965–968
   PubMed Web of Science ®Google Scholar
• Burton J. D., Bamford R. N., Peters C., Grant A. J., Kyrys G., Goldman C. K., Brennan J., Roessler E., Waldmann T. A. A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc Natl Acad Sci USA 1994; 91: 4935–4939
   PubMed Web of Science ®Google Scholar
• Doherty T. M., Seder R. A., Sher A. Induction and regulation of intereleukin-15 expression in murine macrophages. J Immunol 1996; 156: 735–741
   PubMed Web of Science ®Google Scholar
• Anderson D. M., Johnson L., Glaccum M. B., Copeland N. G., Gilbert D. J., Jenkins N. A., Valentine V., Kirstein M. N., Shapiro D. N., Morris S. W., Grabstein K., Cosman D. Chromosomal assignment and genomic structure of IL15. Genomics 1995; 25: 701–706
   PubMed Web of Science ®Google Scholar
• Agostini C., Trentin L., Facco M., Sancetta R., Cerutti A., Tassinari C., Cimarosto L., Adami F., Cipriani A., Zambello R., Semenzato G. Role of IL-15, IL-2, and their receptors in the development of T cell alveolitis in pulmonary sarcoidosis. J Immunol 1996; 157: 910–918
   PubMed Web of Science ®Google Scholar
• Zambello R., Facco M., Trentin L., Sancetta R., Tassinari C., Perin A., Milani A., Pizzolo G., Rodeghiero F., Agostini C., Meazza R., Ferrini S., Semenzato G. IL-15 triggers the proliferation and the cytotoxicity of granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes. Blood 1996; 89, (in press)
   Web of Science ®Google Scholar
• Bamford R. N., Battiata A. P., Waldmann T. A. IL-15: the role of translational regulation in their expression. J Leuc Biol 1996; 59: 476–480
   PubMed Web of Science ®Google Scholar
• Uchiyama T., Broder S., Waldmann T. A. A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T-cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac(+) cells. J Immunol 1981; 126: 1393–1400
   PubMed Web of Science ®Google Scholar
• Wang H. M., Smith K. A. The interleukin 2 receptor: Functional consequences of its bimolecular structure. J Exp Med 1987; 166: 1055–1067
   PubMed Web of Science ®Google Scholar
• Tsudo M., Kitamura F., Myasaka M. Characterization of the interleukin 2 receptor β chain using three distinct monoclonal antibodies. Proc Natl Acad Sci USA 1989; 86: 1982–1986
   PubMed Web of Science ®Google Scholar
• Takeshita T., Goto Y., Kada K., Nagata K., Asao H., Sugamura K. Monoclonal antibody defining a molecule possibly identical to the p75 subunit of interleukin 2 receptor. J Exp Med 1989; 169: 1323–1332
   PubMed Web of Science ®Google Scholar
• Tsudo T., Karasuyama H., Kitamura F., Tanaka T., Kubo S., Yamamura Y., Tamatani T., Hatakeyama M., Taniguchi T., Miyasaka M. The IL-2 receptor β-chain (p70): ligand binding ability of the cDNA-encod-ing membrane and secreted forms. J Immunol 1990; 145: 599–604
   PubMed Web of Science ®Google Scholar
• Waldmann T. A. The interleukin-2 receptor. J Biol Chem 1991; 266: 2681–2684
   PubMed Web of Science ®Google Scholar
• Takeshita T., Ohtani K., Asao H., Kumaki S., Nakamura M., Sugamura K. An associated molecule, p64, with IL-2 receptor β chain. Its possible involvement in the formation of the functional intermediate-affinity IL-2 receptor complex. J Immunol 1992; 148: 2154–2158
   PubMed Web of Science ®Google Scholar
• Minami Y., Kono T., Miyazaki T., Taniguchi T. The interleukin-2 receptor complex: its structure, function, and target genes. Annu Rev Immunol 1993; 11: 245–268
   PubMed Web of Science ®Google Scholar
• Noguchi M., Nakamura Y., Russel S. M., Ziegler S. F., Tsang M., Cao X., Leonard W. J. Interleukin-2 receptor gamma chain: a functional component of the IL-7 receptor. Science 1993; 262: 1877–1879
   PubMed Web of Science ®Google Scholar
• Kondo M., Takeshita T., Ishii N., Nakamura Y., Watanabe S., Arai K.-I., Sugamura K. Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4. Science 1993; 262: 1874–1876
   PubMed Web of Science ®Google Scholar
• Russel S. M., Keegan Y., Harada N., Nakamura Y., Noguchi M., Leland P., Friedmann M. C., Miyajima A., Pun P. K., Paul W. E., Leonard W. J. Interleukin-2 receptor gamma chain: a functional component of the IL-4 receptor. Science 1993; 262: 1880–1882
   PubMed Web of Science ®Google Scholar
• Bamford R. N., Grant A. J., Burton J. D., Peters C., Kurys G., Goldman C. K., Brennan J., Roessler E., Waldmann T. A. The interleukin (IL) 2 receptor β chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc Natl Acad Sci USA 1994; 91: 4940–4944
   PubMed Web of Science ®Google Scholar
• Giri J. G., Ahdieh M., Eisenman J., Shanebeck K., Grabstein K. H., Kumaki S., Namen A., Park L. S., Cosman D., Anderson D. Utilization of the β and γ chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J 1994; 13: 2822–2830
   PubMed Web of Science ®Google Scholar
• Gin J. G., Kumaki S., Ahdieh M., Friend D. J., Loomis A., Shanebeck K., DuBose R., Cosman D., Park L. S. Identification and cloning of a novel IL-15 binding protein that is structurally related to the α chain of the IL-2 receptor. EMBO J 1995; 14: 3654–3663
   PubMed Web of Science ®Google Scholar
• Anderson D. M., Kumaki S., Ahdieh M., Bertles J., Tometsko M., Loomist A., Gin J., Copeland N. G., Gilbert D. J., Jenkins N. A., Valentine V., Shapiro D. N., Morris S. W., Park L. S., Cosman D. Functional characterization of the human interleukin-15 receptor α chain and close linkage of IL15RA and IL2RA genes. J Bid Chem 1995; 270: 29862–29869
   PubMed Web of Science ®Google Scholar
• Bazan J. F. Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci USA 1990; 87: 6934–6938
   PubMed Web of Science ®Google Scholar
• Carson W. E., Gin J. G., Lindemann M. J., Linett M. L., Ahdieh M., Paxton R., Anderson D., Eisenman J., Grabstein K., Caligiuri M. A. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med 1994; 180: 1395–1403
   PubMed Web of Science ®Google Scholar
• Puzanov I. J., Bennet M., Kumar V. IL-15 can substitute for marrow microenvironment in the differentiation of natural killer cells. J Immunol 1996; 157: 4282–4285
   PubMed Web of Science ®Google Scholar
• Gamero A. M., Ussery D., Reintgen D. S., Puleo C. A., Djeu J. Y. Interleukin 15 induction of lymphokine-activated killer cell function against autologous tumor cells in melanoma patient lymphocytes by a CD18-dependent, per-fonn-related mechanism. Cancer Res 1995; 55: 4988–4993
   PubMed Web of Science ®Google Scholar
• Warren H. S., Kinnear B. F., Kastelein R. L., Lanier L. L. Analysis of the costimulatory role of IL-2 and IL-15 in initiating proliferation of resting (CD56dim) human NK cells. J Immunol 1996; 156: 3254–3259
   PubMed Web of Science ®Google Scholar
• Armitage R. J., Macduff B. M., Eisenman J., Paxton R., Grabstein K. H. IL-15 has stimulatory activity for the induction of B-cell proliferation and differentiation. J Immunol 1995; 154: 483–490
   PubMed Web of Science ®Google Scholar